17 Bionanotechnology for Gene and Drug Delivery I


Description:
Bionanotechnology uses concepts from chemistry, physics, and molecular biology to identify components and processes for the construction of nanomaterials and nanodevices for health care. This session invites papers that focus on the design and development of nanomaterials and nanodevices for gene and drug delivery. Topics of interest include, but are not limited to: novel methods and compositions to design gene and drug delivery systems at the nanoscale level, and the effects of the sizes of gene and drug delivery systems on gene and drug release kinetics, and pharmacokinetics, cellular uptake, biological transport, and bioefficacy of gene- and drug-carrier complexes. Bionanotechnology Graduate students: By applying to this session you may be eligible for the 22b Bionanotechnology Graduate Student Award Session (22B09) established to honor students whose research achievements in bionanotechnology demonstrates a high level of excellence. See session 22B09 for more details.

Sponsor:
Bionanotechnology
Co-Sponsor(s):
Biomaterials (08B)


Chair:
Joo-Youp Lee
Associate Professor
University of Cincinnati
Chemical Engineering
Cincinnati, OH
45221
Email: joo.lee@uc.edu

Co-chairs:
Elizabeth Nance
Assistant Professor
University of Washington
Chemical Engineering
Seattle, WA
Phone Number: 206-543-2216
Email: eanance@uw.edu

Yoonjee Park
Assistant Professor
University of Cincinnati
Biomedical, Chemical & Environmental Engineering
Cincinnati, OH
Phone Number: 5135561359
Email: parkye@ucmail.uc.edu

Aaron C. Anselmo
Massachusetts Institute of Technology
Koch Institute for Integrative Cancer Research
Cambridge, MA
93106
Email: Aaroncanselmo@gmail.com


Papers:
17a
Core Crosslinked Nanoparticles for Treating Traumatic Brain Injury
Forrest Kievit, University of Nebraska; Christine Yoo, University of Washington; Abby M. Kelly, University of Washington; Alexander Magsam, University of Nebraska; Patrick S. Stayton, University of Washington; Anthony J. Convertine, University of Washington
17b
Targeted Polyanhydride Nanoparticles to Combat Neurodegeneration
Benjamin Schlichtmann, Iowa State University; Shivani Ghaisas, Iowa State University; Vellareddy Anantharam, Iowa State University; Anumantha Kanthasamy, Iowa State University; Surya Mallapragada, Iowa State University; Balaji Narasimhan, Iowa State University
17c
ssDNA Nanotubes Targeting Glioblastoma Multiforme
Michael A. Harris, University of Minnesota; Maple Shiao, University of Minnesota; Huihui Kuang, University of Minnesota; Walter C. Low, University of Minnesota; Efrosini Kokkoli, University of Minnesota
17d
Enzyme-Encapsulating Polymeric Nanoparticles for Treating Glutamate Excitotoxicity
Rick Liao, University of Washington; Catherine Panlilio, University of Washington; Belinda Garana, University of Washington; Elizabeth Nance, University of Washington
17e
Design of Self-Assembled Nanostructures Built from Immune Signals to Combat Autoimmune Disease
Lisa Tostanoski, University of Maryland; Christopher M. Jewell, University of Maryland
17f
siRNA Loaded Lipidoid Nanoparticles for Diabetic Ulcer Treatment
Lisa Kasiewicz, Carnegie Mellon University; Kathryn A. Whitehead, Carnegie Mellon University
17h
Sequential Co-Delivery of EGFR Inhibitor and Doxorubicin for Targeted Combination Chemotherapy
Zilan Zhou, University of Cincinnati; Joo-Youp Lee, University of Cincinnati; Mina Jafari, University of Cincinnati
Abstract Submissions Closed
See more of this Group/Topical: Nanoscale Science and Engineering Forum
<< Previous Session | Next Session >>